Is Trigyn Techno. overvalued or undervalued?

As of 17 October 2025, Trigyn Technologies has moved from an expensive to a fair valuation grade. The company is currently fairly valued, despite its troubling financial ratios, including a PE ratio of -2570.38, an EV to EBITDA of -25.25, and a Price to Book Value of 0.32. These figures indicate significant challenges in profitability and capital efficiency.
In comparison to its peers, Trigyn's valuation metrics stand out negatively; for instance, TCS has a PE ratio of 21.31 and an EV to EBITDA of 8.21, while Infosys shows a PE of 21.29 and an EV to EBITDA of 4.65. Despite the fair valuation grade, Trigyn's stock has underperformed relative to the Sensex, with a year-to-date return of -28.40% compared to the Sensex's 7.44%. This underperformance, along with the concerning financial ratios, suggests that while the stock may be fairly valued, it faces significant operational challenges ahead.